Drugs Information: Certolizumab pegol
Basic Information
|
||
ID | DDInter342 | |
Drug Type | biotech | |
Molecular Formula | C2115H3252N556O673S16 | |
Molecular Weight | - | |
Description | Certolizumab pegol is a tumor necrosis factor (TNF) blocker used to treat a variety of autoimmune and autoinflammatory conditions like Crohn's disease, rheumatoid arthritis, active psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, and plaque psoriasis. | |
ATC Classification | L04AB05 | |
IUPAC Name | None | |
InChI | None | |
InChI Key | None | |
Canonical SMILES | None | |
Useful Links | DrugBank |
Interactions with Certolizumab pegol
Severity level | ID | Name | Mechanism | Detail |
---|